Helus Pharma Inc.
- Last sale
- Nov 12, 2026 · -5.54%
- Market cap
- $457.97M
- 51.63M shares
- Filings
- 461
FY 2022−100.0% FY22 yoy
FY 2026N/M FY26 yoy
—
—
—FY 2024derivedN/M FY24 yoy
FY 2026N/M FY26 yoy
FY 2026+67.4% FY26 yoy
- $457.97M
- —
- —
- 2.0×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-03-31 | CA$0 | reported | |
| FY 2021 | 2021-03-31 | CA$864,000 | reported |
Pharmaceutical preparations
Helus Pharma Inc. is the 193rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
EPRXEupraxia Pharmaceuticals Inc.$0.0——$472.1MMNPRMonopar Therapeutics$0.0——$469.5MSVASinovac Biotech Ltd$386.0M6.8%51.5%$464.9M
HELPHelus Pharma Inc. (this company)———$458.0M
KMDAKamada Ltd$180.5M12.1%11.2%$452.8MAQSTAquestive Therapeutics, Inc.$44.5M22.6%188.1%$448.7MRLMDRelmada Therapeutics, Inc.———$444.9MAVTXAvalo Therapeutics, Inc.$59.0K86.6%132,642.4%$444.4MCTMXCytomX Therapeutics, Inc.$76.2M44.8%22.8%$442.5MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Helus Pharma Inc. · CIK 1833141 · Engraved from SEC EDGAR